Essential roles of the histone methyltransferase ESET in the epigenetic control of neural progenitor cells during development
SL Tan, M Nishi, T Ohtsuka, T Matsui… - …, 2012 - journals.biologists.com
In the developing brain, neural progenitor cells switch differentiation competency by
changing gene expression profiles that are governed partly by epigenetic control, such as …
changing gene expression profiles that are governed partly by epigenetic control, such as …
Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma
L Gossage, M Murtaza, AF Slatter… - Genes …, 2014 - Wiley Online Library
VHL is mutated in the majority of patients with clear cell renal cell carcinoma (ccRCC), with
conflicting clinical relevance. Recent studies have identified recurrent mutations in histone …
conflicting clinical relevance. Recent studies have identified recurrent mutations in histone …
Comparative genomic analysis of primary and synchronous metastatic colorectal cancers
Approximately 50% of patients with primary colorectal carcinoma develop liver metastases.
Understanding the genetic differences between primary colon cancer and their metastases …
Understanding the genetic differences between primary colon cancer and their metastases …
Genomics and epigenomics of clear cell renal cell carcinoma: recent developments and potential applications
M Rydzanicz, T Wrzesiński, HAR Bluyssen, J Wesoły - Cancer letters, 2013 - Elsevier
Majority of clear cell renal cell carcinomas (ccRCCs) are diagnosed in the advanced
metastatic stage resulting in dramatic decrease of patient survival. Thereby, early detection …
metastatic stage resulting in dramatic decrease of patient survival. Thereby, early detection …
Actionable mutations in canine hemangiosarcoma
G Wang, M Wu, MA Maloneyhuss, J Wojcik… - PloS one, 2017 - journals.plos.org
Background Angiosarcomas (AS) are rare in humans, but they are a deadly subtype of soft
tissue sarcoma. Discovery sequencing in AS, especially the visceral form, is hampered by …
tissue sarcoma. Discovery sequencing in AS, especially the visceral form, is hampered by …
Liquid biopsies for management of pancreatic cancer
Pancreatic cancer is one of the main causes of cancer-related deaths worldwide. It is
asymptomatic at an early stage, and most diagnosis occurs when the disease is already at a …
asymptomatic at an early stage, and most diagnosis occurs when the disease is already at a …
Multilayer‐omics analysis of renal cell carcinoma, including the whole exome, methylome and transcriptome
E Arai, H Sakamoto, H Ichikawa… - … journal of cancer, 2014 - Wiley Online Library
The aim of this study was to identify pathways that have a significant impact during renal
carcinogenesis. Sixty‐seven paired samples of both noncancerous renal cortex tissue and …
carcinogenesis. Sixty‐seven paired samples of both noncancerous renal cortex tissue and …
New developments in the molecular mechanisms of pancreatic tumorigenesis
M Felsenstein, RH Hruban… - Advances in anatomic …, 2018 - journals.lww.com
Pancreatic cancer is an aggressive disease with a dismal prognosis in dire need of novel
diagnostic and therapeutic approaches. The past decade has witnessed an explosion of …
diagnostic and therapeutic approaches. The past decade has witnessed an explosion of …
Epigenome aberrations: emerging driving factors of the clear cell renal cell carcinoma
A Mehdi, Y Riazalhosseini - International journal of molecular sciences, 2017 - mdpi.com
Clear cell renal cell carcinoma (ccRCC), the most common form of Kidney cancer, is
characterized by frequent mutations of the von Hippel-Lindau (VHL) tumor suppressor gene …
characterized by frequent mutations of the von Hippel-Lindau (VHL) tumor suppressor gene …
[HTML][HTML] Molecular alterations in pancreatic tumors
M Visani, G Acquaviva, A De Leo, V Sanza… - World journal of …, 2021 - ncbi.nlm.nih.gov
Genetic alterations in pancreatic tumors can usually be classified in:(1) Mutational activation
of oncogenes;(2) Inactivation of tumor suppressor genes; and (3) Inactivation of genome …
of oncogenes;(2) Inactivation of tumor suppressor genes; and (3) Inactivation of genome …